GSK233705 and GW642444

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 1

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

CompletedNCT00671216

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2008-05-20End: 2008-07-07Updated: 2017-10-04

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

CompletedNCT00783003

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2008-11-10End: 2009-02-06Updated: 2017-07-18